Construct validity of different modifications of the mSCQ and the RDCI with health outcomes in all patients, and subgroups of patients with axSpA and pSpA
. | Age . | BASFI . | EQ-5D . | patient's global assessment of well-being . | WPAI, impact on work productivitya . | Impact on daily activities . | ASDAS- CRP . |
---|---|---|---|---|---|---|---|
All patients (n = 3984) | |||||||
mSCQ | 0.41 | 0.34 | −0.33 | 0.22 | 0.21 | 0.30 | 0.19 |
mSCQ + EAMs | 0.45 | 0.32 | −0.33 | 0.19c | 0.16c | 0.26c | 0.16c |
mSCQ + fractures | 0.40 | 0.34 | −0.33 | 0.21 | 0.20 | 0.29 | 0.19 |
mSCQ + osteoporosis + fracture | 0.41 | 0.34 | −0.33 | 0.22 | 0.21 | 0.30 | 0.19 |
mSCQ + EAMs + osteoporosis | 0.46c | 0.32 | −0.33 | 0.20 | 0.17c | 0.27 | 0.16c |
mSCQ + EAMs + fractures | 0.45 | 0.32 | −0.33 | 0.19c | 0.17c | 0.27 | 0.16c |
mSCQ + EAMs + osteoporosis + fractures | 0.45 | 0.33 | −0.33 | 0.20 | 0.17c | 0.27 | 0.17 |
RDCIb | 0.47c | 0.24c | −0.21c | 0.12c | 0.09c | 0.17c | 0.10c |
Patients fulfilling ASAS axSpA criteria (n = 2955) | |||||||
mSCQ | 0.38 | 0.35d | −0.35d | 0.21d | 0.20d | 0.29d | 0.19d |
mSCQ + EAMs | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.27 | 0.17c,d |
mSCQ + fractures | 0.38 | 0.35d | −0.34d | 0.21d | 0.20d | 0.30d | 0.18d |
mSCQ + osteoporosis + fracture | 0.39 | 0.35d | −0.34 | 0.22d | 0.20d | 0.30d | 0.19d |
mSCQ + EAMs + osteoporosis | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.28 | 0.18d |
mSCQ + EAMs + fractures | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.27 | 0.17c,d |
mSCQ + EAMs + osteoporosis + fractures | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.28 | 0.17c,d |
RDCIb | 0.44c | 0.25c,d | −0.22c | 0.12c,d | 0.08c,d | 0.17c,d | 0.10c,d |
Patients fulfilling ASAS pSpA criteria (n = 415) | |||||||
mSCQ | 0.40 | 0.46d | −0.29d | 0.19d | 0.29d | 0.32d | 0.25d |
mSCQ + EAMs | 0.45c | 0.35c | −0.29d | 0.15c,d | 0.22c,d | 0.27c | 0.19c,d |
mSCQ + fractures | 0.40 | 0.41c,d | −0.30d | 0.18d | 0.30d | 0.33d | 0.26d |
mSCQ + osteoporosis + fracture | 0.40 | 0.42d | −0.31 | 0.19d | 0.32c,d | 0.34d | 0.26d |
mSCQ + EAMs + osteoporosis | 0.45c | 0.36c | −0.27d | 0.16c,d | 0.24c,d | 0.28 | 0.19c |
mSCQ + EAMs + fractures | 0.45c | 0.37c | −0.26c,d | 0.15c,d | 0.24c,d | 0.27c | 0.19c,d |
mSCQ + EAMs + osteoporosis + fractures | 0.46c | 0.37c | −0.27d | 0.15c,d | 0.26c,d | 0.29 | 0.20c,d |
RDCIb | 0.42 | 0.35c,d | −0.23c | 0.16c,d | 0.25c,d | 0.24c,d | 0.22c,d |
. | Age . | BASFI . | EQ-5D . | patient's global assessment of well-being . | WPAI, impact on work productivitya . | Impact on daily activities . | ASDAS- CRP . |
---|---|---|---|---|---|---|---|
All patients (n = 3984) | |||||||
mSCQ | 0.41 | 0.34 | −0.33 | 0.22 | 0.21 | 0.30 | 0.19 |
mSCQ + EAMs | 0.45 | 0.32 | −0.33 | 0.19c | 0.16c | 0.26c | 0.16c |
mSCQ + fractures | 0.40 | 0.34 | −0.33 | 0.21 | 0.20 | 0.29 | 0.19 |
mSCQ + osteoporosis + fracture | 0.41 | 0.34 | −0.33 | 0.22 | 0.21 | 0.30 | 0.19 |
mSCQ + EAMs + osteoporosis | 0.46c | 0.32 | −0.33 | 0.20 | 0.17c | 0.27 | 0.16c |
mSCQ + EAMs + fractures | 0.45 | 0.32 | −0.33 | 0.19c | 0.17c | 0.27 | 0.16c |
mSCQ + EAMs + osteoporosis + fractures | 0.45 | 0.33 | −0.33 | 0.20 | 0.17c | 0.27 | 0.17 |
RDCIb | 0.47c | 0.24c | −0.21c | 0.12c | 0.09c | 0.17c | 0.10c |
Patients fulfilling ASAS axSpA criteria (n = 2955) | |||||||
mSCQ | 0.38 | 0.35d | −0.35d | 0.21d | 0.20d | 0.29d | 0.19d |
mSCQ + EAMs | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.27 | 0.17c,d |
mSCQ + fractures | 0.38 | 0.35d | −0.34d | 0.21d | 0.20d | 0.30d | 0.18d |
mSCQ + osteoporosis + fracture | 0.39 | 0.35d | −0.34 | 0.22d | 0.20d | 0.30d | 0.19d |
mSCQ + EAMs + osteoporosis | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.28 | 0.18d |
mSCQ + EAMs + fractures | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.27 | 0.17c,d |
mSCQ + EAMs + osteoporosis + fractures | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.28 | 0.17c,d |
RDCIb | 0.44c | 0.25c,d | −0.22c | 0.12c,d | 0.08c,d | 0.17c,d | 0.10c,d |
Patients fulfilling ASAS pSpA criteria (n = 415) | |||||||
mSCQ | 0.40 | 0.46d | −0.29d | 0.19d | 0.29d | 0.32d | 0.25d |
mSCQ + EAMs | 0.45c | 0.35c | −0.29d | 0.15c,d | 0.22c,d | 0.27c | 0.19c,d |
mSCQ + fractures | 0.40 | 0.41c,d | −0.30d | 0.18d | 0.30d | 0.33d | 0.26d |
mSCQ + osteoporosis + fracture | 0.40 | 0.42d | −0.31 | 0.19d | 0.32c,d | 0.34d | 0.26d |
mSCQ + EAMs + osteoporosis | 0.45c | 0.36c | −0.27d | 0.16c,d | 0.24c,d | 0.28 | 0.19c |
mSCQ + EAMs + fractures | 0.45c | 0.37c | −0.26c,d | 0.15c,d | 0.24c,d | 0.27c | 0.19c,d |
mSCQ + EAMs + osteoporosis + fractures | 0.46c | 0.37c | −0.27d | 0.15c,d | 0.26c,d | 0.29 | 0.20c,d |
RDCIb | 0.42 | 0.35c,d | −0.23c | 0.16c,d | 0.25c,d | 0.24c,d | 0.22c,d |
Work productivity in those currently employed.
The RDCI was calculated according to the information from the physician, except for depression which was retrieved from the patient.
Difference of comorbidity score with mSCQ score >10%.
Difference on correlation between axSpA and pSpA >10%. EAM: extra-articular manifestations; EQ-5D: Euroqol 5 D; mSCQ: modified self-administered comorbidity index; RDCI: rheumatic disease comorbidity index; WPAI: work productivity and activity impairment.
Construct validity of different modifications of the mSCQ and the RDCI with health outcomes in all patients, and subgroups of patients with axSpA and pSpA
. | Age . | BASFI . | EQ-5D . | patient's global assessment of well-being . | WPAI, impact on work productivitya . | Impact on daily activities . | ASDAS- CRP . |
---|---|---|---|---|---|---|---|
All patients (n = 3984) | |||||||
mSCQ | 0.41 | 0.34 | −0.33 | 0.22 | 0.21 | 0.30 | 0.19 |
mSCQ + EAMs | 0.45 | 0.32 | −0.33 | 0.19c | 0.16c | 0.26c | 0.16c |
mSCQ + fractures | 0.40 | 0.34 | −0.33 | 0.21 | 0.20 | 0.29 | 0.19 |
mSCQ + osteoporosis + fracture | 0.41 | 0.34 | −0.33 | 0.22 | 0.21 | 0.30 | 0.19 |
mSCQ + EAMs + osteoporosis | 0.46c | 0.32 | −0.33 | 0.20 | 0.17c | 0.27 | 0.16c |
mSCQ + EAMs + fractures | 0.45 | 0.32 | −0.33 | 0.19c | 0.17c | 0.27 | 0.16c |
mSCQ + EAMs + osteoporosis + fractures | 0.45 | 0.33 | −0.33 | 0.20 | 0.17c | 0.27 | 0.17 |
RDCIb | 0.47c | 0.24c | −0.21c | 0.12c | 0.09c | 0.17c | 0.10c |
Patients fulfilling ASAS axSpA criteria (n = 2955) | |||||||
mSCQ | 0.38 | 0.35d | −0.35d | 0.21d | 0.20d | 0.29d | 0.19d |
mSCQ + EAMs | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.27 | 0.17c,d |
mSCQ + fractures | 0.38 | 0.35d | −0.34d | 0.21d | 0.20d | 0.30d | 0.18d |
mSCQ + osteoporosis + fracture | 0.39 | 0.35d | −0.34 | 0.22d | 0.20d | 0.30d | 0.19d |
mSCQ + EAMs + osteoporosis | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.28 | 0.18d |
mSCQ + EAMs + fractures | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.27 | 0.17c,d |
mSCQ + EAMs + osteoporosis + fractures | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.28 | 0.17c,d |
RDCIb | 0.44c | 0.25c,d | −0.22c | 0.12c,d | 0.08c,d | 0.17c,d | 0.10c,d |
Patients fulfilling ASAS pSpA criteria (n = 415) | |||||||
mSCQ | 0.40 | 0.46d | −0.29d | 0.19d | 0.29d | 0.32d | 0.25d |
mSCQ + EAMs | 0.45c | 0.35c | −0.29d | 0.15c,d | 0.22c,d | 0.27c | 0.19c,d |
mSCQ + fractures | 0.40 | 0.41c,d | −0.30d | 0.18d | 0.30d | 0.33d | 0.26d |
mSCQ + osteoporosis + fracture | 0.40 | 0.42d | −0.31 | 0.19d | 0.32c,d | 0.34d | 0.26d |
mSCQ + EAMs + osteoporosis | 0.45c | 0.36c | −0.27d | 0.16c,d | 0.24c,d | 0.28 | 0.19c |
mSCQ + EAMs + fractures | 0.45c | 0.37c | −0.26c,d | 0.15c,d | 0.24c,d | 0.27c | 0.19c,d |
mSCQ + EAMs + osteoporosis + fractures | 0.46c | 0.37c | −0.27d | 0.15c,d | 0.26c,d | 0.29 | 0.20c,d |
RDCIb | 0.42 | 0.35c,d | −0.23c | 0.16c,d | 0.25c,d | 0.24c,d | 0.22c,d |
. | Age . | BASFI . | EQ-5D . | patient's global assessment of well-being . | WPAI, impact on work productivitya . | Impact on daily activities . | ASDAS- CRP . |
---|---|---|---|---|---|---|---|
All patients (n = 3984) | |||||||
mSCQ | 0.41 | 0.34 | −0.33 | 0.22 | 0.21 | 0.30 | 0.19 |
mSCQ + EAMs | 0.45 | 0.32 | −0.33 | 0.19c | 0.16c | 0.26c | 0.16c |
mSCQ + fractures | 0.40 | 0.34 | −0.33 | 0.21 | 0.20 | 0.29 | 0.19 |
mSCQ + osteoporosis + fracture | 0.41 | 0.34 | −0.33 | 0.22 | 0.21 | 0.30 | 0.19 |
mSCQ + EAMs + osteoporosis | 0.46c | 0.32 | −0.33 | 0.20 | 0.17c | 0.27 | 0.16c |
mSCQ + EAMs + fractures | 0.45 | 0.32 | −0.33 | 0.19c | 0.17c | 0.27 | 0.16c |
mSCQ + EAMs + osteoporosis + fractures | 0.45 | 0.33 | −0.33 | 0.20 | 0.17c | 0.27 | 0.17 |
RDCIb | 0.47c | 0.24c | −0.21c | 0.12c | 0.09c | 0.17c | 0.10c |
Patients fulfilling ASAS axSpA criteria (n = 2955) | |||||||
mSCQ | 0.38 | 0.35d | −0.35d | 0.21d | 0.20d | 0.29d | 0.19d |
mSCQ + EAMs | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.27 | 0.17c,d |
mSCQ + fractures | 0.38 | 0.35d | −0.34d | 0.21d | 0.20d | 0.30d | 0.18d |
mSCQ + osteoporosis + fracture | 0.39 | 0.35d | −0.34 | 0.22d | 0.20d | 0.30d | 0.19d |
mSCQ + EAMs + osteoporosis | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.28 | 0.18d |
mSCQ + EAMs + fractures | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.27 | 0.17c,d |
mSCQ + EAMs + osteoporosis + fractures | 0.42c | 0.34 | −0.34d | 0.20d | 0.17c,d | 0.28 | 0.17c,d |
RDCIb | 0.44c | 0.25c,d | −0.22c | 0.12c,d | 0.08c,d | 0.17c,d | 0.10c,d |
Patients fulfilling ASAS pSpA criteria (n = 415) | |||||||
mSCQ | 0.40 | 0.46d | −0.29d | 0.19d | 0.29d | 0.32d | 0.25d |
mSCQ + EAMs | 0.45c | 0.35c | −0.29d | 0.15c,d | 0.22c,d | 0.27c | 0.19c,d |
mSCQ + fractures | 0.40 | 0.41c,d | −0.30d | 0.18d | 0.30d | 0.33d | 0.26d |
mSCQ + osteoporosis + fracture | 0.40 | 0.42d | −0.31 | 0.19d | 0.32c,d | 0.34d | 0.26d |
mSCQ + EAMs + osteoporosis | 0.45c | 0.36c | −0.27d | 0.16c,d | 0.24c,d | 0.28 | 0.19c |
mSCQ + EAMs + fractures | 0.45c | 0.37c | −0.26c,d | 0.15c,d | 0.24c,d | 0.27c | 0.19c,d |
mSCQ + EAMs + osteoporosis + fractures | 0.46c | 0.37c | −0.27d | 0.15c,d | 0.26c,d | 0.29 | 0.20c,d |
RDCIb | 0.42 | 0.35c,d | −0.23c | 0.16c,d | 0.25c,d | 0.24c,d | 0.22c,d |
Work productivity in those currently employed.
The RDCI was calculated according to the information from the physician, except for depression which was retrieved from the patient.
Difference of comorbidity score with mSCQ score >10%.
Difference on correlation between axSpA and pSpA >10%. EAM: extra-articular manifestations; EQ-5D: Euroqol 5 D; mSCQ: modified self-administered comorbidity index; RDCI: rheumatic disease comorbidity index; WPAI: work productivity and activity impairment.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.